Case number 1:23-cv-00879
Pfizer Inc. et al v. Dexcel Pharma Technologies Limited, et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 3, 2025 | 217 | REDACTED VERSION of 210 Stipulation, by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 07/03/2025) (3) |
| Jun 30, 2025 | 215 | NOTICE OF SERVICE of (1) Opening Expert Report of Adam Matzger, Ph.D. and (2) Report of Aeri Park, Ph.D. Regarding Cipla's Samples filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 06/30/2025) (3) |
| Jun 30, 2025 | 216 | NOTICE OF SERVICE of (1) Opening Expert Report of Adam Matzger, Ph.D. and (2) Report of Aeri Park, Ph.D. Regarding Zenara's (Hikma's) Samples filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 06/30/2025) (3) |
| Jun 27, 2025 | 210 | [SEALED] STIPULATION and [Proposed] Order Regarding Limited Extension of Fact Discovery Deadline for Completion of Foreign Discovery by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 06/27/2025) (0) |
| Jun 27, 2025 | 211 | STIPULATION and [PROPOSED] Order regarding Authenticity and Admissibility of Documents by Cipla Limited. (Taylor, Daniel) (Entered: 06/27/2025) (3) |
| Jun 27, 2025 | 212 | NOTICE OF SERVICE of Defendants' confidential Opening Expert Report of Dr. Michael Zaworotko, Ph.D. filed by Cipla Limited.(Taylor, Daniel) (Entered: 06/27/2025) (2) |
| Jun 27, 2025 | 213 | NOTICE OF SERVICE of 1) Opening Expert Report of Jerry L. Atwood, Ph.D.; 2) Opening Expert Report of David E. Bugay, Ph.D.; 3) Opening Expert Report of Karthikeyan Ananthasubramaniam, M.D.; and 4) Expert Report of Sylvia D. Hall-Ellis, Ph.D. filed by Dexcel Pharma Technologies Limited.(Mackrides, Daniel) (Entered: 06/27/2025) (2) |
| Jun 27, 2025 | 214 | NOTICE OF SERVICE of Opening Expert Report of Dr. Michael Zaworotko, Ph. D. filed by Dexcel Pharma Technologies Limited.(Mackrides, Daniel) (Entered: 06/27/2025) (2) |
| Jun 23, 2025 | 208 | NOTICE of Change of Address by Hikma Pharmaceuticals USA Inc. (Gattuso, Dominick) (Entered: 06/23/2025) (2) |
| Jun 23, 2025 | 209 | NOTICE OF SERVICE of Plaintiffs' Fifth Supplemental Responses and Objections to Defendants' First Set of Collective Interrogatories (Nos. 1-3) - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 06/23/2025) (5) |
| Jun 3, 2025 | 207 | NOTICE OF SERVICE of Defendant, Aurobindo Pharma Limited's Second Supplemental Responses and Objections to Plaintiffs' Second Set of Interrogatories (Nos. 3-6) filed by Aurobindo Pharma Limited.(Myer, R.) (Entered: 06/03/2025) (2) |
| May 30, 2025 | 205 | NOTICE OF SERVICE of Defendants Aurobindo and Dexcel's Final Invalidity Contentions for U.S. Patent Nos. 7,214,695 and 7,214,696 filed by Dexcel Pharma Technologies Limited.(Gaza, Anne) (Entered: 05/30/2025) (2) |
| May 30, 2025 | 206 | NOTICE OF SERVICE of Defendants Dexcel, Cipla, and Hikma's Final Invalidity Contentions for U.S. Patent No. 9,770,441 filed by Dexcel Pharma Technologies Limited.(Gaza, Anne) (Entered: 05/30/2025) (2) |
| May 23, 2025 | 204 | NOTICE of Withdrawal of Counsel by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC (Dellinger, Megan) (Entered: 05/23/2025) (3) |
| May 19, 2025 | 202 | MOTION for Pro Hac Vice Appearance of Attorney Tyler C. Liu - filed by Dexcel Pharma Technologies Limited. Motions referred to Christopher J. Burke.(Mackrides, Daniel) (Entered: 05/19/2025) (4) |
| May 19, 2025 | 203 | Pro Hac Vice Fee - Credit Card Payment received for Tyler C. Liu. ( re 202 MOTION for Pro Hac Vice Appearance of Attorney Tyler C. Liu )( Payment of $ 50, receipt number ADEDC-4690540).(Mackrides, Daniel) (Entered: 05/19/2025) (0) |
| May 16, 2025 | 200 | Letter to The Honorable Christopher J. Burke from Anne Shea Gaza regarding Reply Letter Brief in Support of Defendant Dexcel Pharma Technologies' Motion to Compel Plaintiffs to Produce Requested Contention Documents - re 195 Joint MOTION to Resolve Discovery Dispute re 185 Oral Order . (Attachments: # 1 Exhibit E)(Gaza, Anne) Modified on 5/19/2025 (sam). (Entered: 05/16/2025) (0) |
| May 16, 2025 | 201 | NOTICE OF SERVICE of Plaintiffs' Final Disclosure of Asserted Claims and Infringement Contentions for ANDA Product (Individual Set Served on Each Defendant Group) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 05/16/2025) (4) |
| May 12, 2025 | 199 | Joint Letter to The Honorable Christopher J. Burke from Daniel A. Taylor regarding Co-Defendants Cipla Limited and Hikma Pharmaceuticals USA Inc.'s Answering Letter Brief in Opposition to 196 Opening Letter Brief in Support of Defendant Dexcel Pharma Technologies Limited's 195 Joint Motion to Compel Plaintiffs to Produce Requested Contention Documents. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Taylor, Daniel) (Entered: 05/12/2025) (0) |
| May 7, 2025 | 197 | REDACTED VERSION of 188 Stipulation by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 05/07/2025) (2) |
| May 7, 2025 | 198 | REDACTED VERSION of 189 Stipulation by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 05/07/2025) (2) |
| May 5, 2025 | 194 | [SEALED] SO ORDERED, re 188 Stipulation filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Signed by Judge Gregory B. Williams on 5/5/2025.This document will be emailed to local counsel. (lnb) (Entered: 05/05/2025) (0) |
| May 5, 2025 | 195 | Joint MOTION to Resolve Discovery Dispute re 185 Oral Order,,,,,, - filed by Dexcel Pharma Technologies Limited. Motions referred to Christopher J. Burke.(Gaza, Anne) (Entered: 05/05/2025) (4) |
| May 5, 2025 | 196 | Letter to The Honorable Christopher J. Burke from Anne Shea Gaza regarding Opening Letter Brief in Support of Defendant Dexcel Pharma Technologies's Motion to Compel Plaintiffs to Produce Requested Contention Documents - re 195 Joint MOTION to Resolve Discovery Dispute re 185 Oral Order,,,,,, , 185 Oral Order,,,,,,. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Text of Proposed Order)(Gaza, Anne) (Entered: 05/05/2025) (0) |
| May 2, 2025 | 188 | [SEALED] STIPULATION Regarding Discovery by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 05/02/2025) (0) |
| May 2, 2025 | 189 | [SEALED] STIPULATION Regarding Discovery by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 05/02/2025) (0) |
| May 2, 2025 | 190 | NOTICE OF SERVICE of Plaintiffs' Second Supplemental Objections and Responses and Objections to Dexcel Pharma Technologies Limited's First Set of Interrogatories (Nos. 1-3) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 05/02/2025) (3) |
| May 2, 2025 | 191 | NOTICE OF SERVICE of (1) Plaintiffs' First Supplemental Responses and Objections to Defendants' Second Set of Common Interrogatories (Nos. 4-8); and (2) Plaintiffs' Fourth Supplemental Responses and Objections to Defendants' First Set of Collective Interrogatories (Nos. 1-3) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 05/02/2025) (5) |
| May 2, 2025 | 192 | STIPULATION and [Proposed] Order Regarding Authenticity and Admissibility of Documents by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 05/02/2025) (2) |
| May 2, 2025 | 193 | NOTICE OF SERVICE of Defendant Cipla Limited's Second Supplemental Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-5) and Responses and Objections to Plaintiffs Second Set of Individual Interrogatories (Nos. 6-7) filed by Cipla Limited.(Taylor, Daniel) (Entered: 05/02/2025) (2) |
| Apr 30, 2025 | 187 | NOTICE OF SERVICE of Defendant, Aurobindo Pharma Limited's First Supplemental Responses and Objections to Plaintiffs' Second Set of Interrogatories (Nos. 3-6) filed by Aurobindo Pharma Limited.(Myer, R.) (Entered: 04/30/2025) (2) |
| Apr 28, 2025 | 185 | ORAL ORDER: The Court, having reviewed the April 24, 2025 joint letter, (D.I. 184 ), hereby ORDERS as follows: (1) By May 5, 2025, the parties shall jointly file a Motion To Resolve Discovery Dispute.; (2) By May 5, 2025, the moving party/parties shall file with the Court a letter, not to exceed two (2) single-spaced pages, in no less than 12-point font, outlining the issue in dispute and its position on those issues.; (3) By May 12, 2025, the responding party/parties may jointly file a letter, not to exceed two (2) single-spaced pages, in no less than 12-point font, outlining the reasons for their opposition.; (4) By May 16, 2025, the moving party/parties shall file with the Court a reply letter brief, not to exceed one (1) single-spaced page, in no less than 12-point font.; (5) The parties should also consult and follow Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; and (6) The Court will plan to resolve the dispute on the papers, unless: (a) it determines after reviewing the briefing that oral argument is needed; or (b) any party advises the Court in advance that, were argument to be set, a newer attorney will argue the dispute(s), see Standing Order Regarding Courtroom Opportunities for Newer Attorneys, https://www.ded.uscourts.gov/sites/ded/files/StandingOrder2017.pdf. If either of those circumstances occurs, then the Court will schedule oral argument on the dispute(s) in the future. Ordered by Judge Christopher J. Burke on 04/28/2025. (sam) (Entered: 04/28/2025) (0) |
| Apr 28, 2025 | 186 | NOTICE OF SERVICE of Defendant Dexcel Pharma Technologies Limited's Second Supplemental Responses and Objections to Plaintiffs' First Set of Interrogatories (No. 1) filed by Dexcel Pharma Technologies Limited.(Gaza, Anne) (Entered: 04/28/2025) (2) |
| Apr 24, 2025 | 183 | STIPULATION and [Proposed] Order Regarding Authenticity and Admissibility of Documents (as to Defendant Cipla Limited) -- by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., Wyeth LLC. (Dellinger, Megan) (Entered: 04/24/2025) (2) |
| Apr 24, 2025 | 184 | Joint Letter to The Honorable Christopher J. Burke from Anne Shea Gaza regarding Discovery Disputes. (Mackrides, Daniel) (Entered: 04/24/2025) (2) |
| Apr 23, 2025 | 182 | NOTICE OF SERVICE of Plaintiffs' Second Set of Individual Interrogatories to Defendant Cipla Limited (Nos. 6-7) - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 04/23/2025) (3) |
| Apr 21, 2025 | 179 | NOTICE OF SERVICE of (1) Defendant, Aurobindo Pharma Limited's Responses and Objections to Plaintiffs' Second Set of Interrogatories (Nos. 3-6); and (2) Defendant, Aurobindo Pharma Limited's Responses and Objections to Plaintiffs' First Set of Interrogatories to All Defendants (Nos. 1-6) filed by Aurobindo Pharma Limited.(Myer, R.) (Entered: 04/21/2025) (2) |
| Apr 21, 2025 | 180 | NOTICE to Take Deposition of Ramanaiah Chennuru on April 22, 2025 filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 04/21/2025) (3) |
| Apr 21, 2025 | 181 | NOTICE to Take Deposition of Manohar Surve on April 29, 2025 filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 04/21/2025) (3) |
| Apr 18, 2025 | 177 | NOTICE OF SERVICE of Defendant Dexcel Pharma Technologies Limited's Responses and Objections to Plaintiffs' Second Set of Interrogatories (Nos. 2-5) filed by Dexcel Pharma Technologies Limited.(Gaza, Anne) (Entered: 04/18/2025) (2) |
| Apr 18, 2025 | 178 | NOTICE OF SERVICE of (1) Non-Party Curia Global, Inc. (IN)'s Responses and Objections to Defendant Cipla Limited's Subpoena to Testify in a Civil Action; (2) Non-Party Curia Global, Inc. (IN)'s Responses and Objections to Defendant Cipla Limited's Subpoena to Produce Documents, Information, or Objects or to Permit Inspection of Premises in a Civil Action; (3) Non-Party Curia Global, Inc. (NC)'s Responses and Objections to Defendant Cipla Limited's Subpoena to Testify in a Civil Action; and (4) Non-Party Curia Global, Inc. (NC)'s Responses and Objections to Defendant Cipla Limited's Subpoena to Produce Documents, Information, or Objects or to Permit Inspection of Premises in a Civil Action filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 04/18/2025) (5) |
| Apr 14, 2025 | 172 | NOTICE to Take Deposition of Mr. Pavan Kumar Potturi on April 21, 2025 filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 04/14/2025) (4) |
| Apr 14, 2025 | 173 | NOTICE to Take Deposition of Mr. Kevin Vorderstrasse on May 2, 2025 filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 04/14/2025) (4) |
| Apr 14, 2025 | 174 | NOTICE OF SERVICE of Plaintiffs' Third Supplemental Responses and Objections to Defendants' First Set of Collective Interrogatories (Nos. 1-3) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 04/14/2025) (5) |
| Apr 14, 2025 | 175 | NOTICE to Take Deposition of Michele Crawley on April 23, 2025 filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 04/14/2025) (4) |
| Apr 14, 2025 | 176 | NOTICE OF SERVICE of Dexcel Pharma Technologies Limited's Objections and Responses to Plaintiffs' First Set of Interrogatories to all Defendants (Nos. 1-6) filed by Dexcel Pharma Technologies Limited.(Gaza, Anne) (Entered: 04/14/2025) (2) |
| Apr 7, 2025 | 170 | NOTICE OF SERVICE of Plaintiffs' Second Supplemental Responses and Objections to Defendants' First Set of Collective Interrogatories (Nos. 1-3) - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 04/07/2025) (5) |
| Apr 7, 2025 | 171 | NOTICE OF SERVICE of (i) Hikma Pharmaceutical USA Inc.'s Response to Plaintiffs' First Set of Interrogatories to All Defendants (Nos. 1-6) [CONFIDENTIAL]; and (ii) Zenara's Response to Plaintiffs' First Set of Interrogatories to All Defendants (Nos. 1-6) [CONFIDENTIAL] filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 04/07/2025) (2) |
| Apr 4, 2025 | 169 | NOTICE OF SERVICE of Hikma Pharmaceutical USA Inc.'s Response to Interrogatories 1, 2, and 4 and Zenara's Response to Interrogatory No. 4 from Plaintiffs' First Set of Interrogatories to Hikma (Nos. 1-4) [CONFIDENTIAL] filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 04/04/2025) (2) |
| Apr 1, 2025 | 167 | NOTICE to Take Deposition of Atul Daroi on April 18, 2025 filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 04/01/2025) (3) |
| Apr 1, 2025 | 168 | NOTICE OF SERVICE of (i) Second Amended Rule 26 Initial Disclosures and (ii) Amended Disclosures Pursuant to Delaware Default Standard Paragraph 3 filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 04/01/2025) (2) |
| Mar 31, 2025 | 166 | NOTICE OF SERVICE of Defendant Cipla Limited's Responses and Objections to Plaintiffs' First Set of Interrogatories to All Defendants (Nos. 1-6) filed by Cipla Limited.(Taylor, Daniel) (Entered: 03/31/2025) (2) |
| Mar 28, 2025 | 164 | NOTICE OF SERVICE of (i) Hikma Pharmaceuticals USA Inc.'s Response to Plaintiffs' First Set of Requests for Admission to Hikma (Nos. 1-8); and (ii) Hikma Pharmaceuticals USA Inc.'s Response to Interrogatory No. 3 From Plaintiffs' First Set of Interrogatories to Hikma (Nos. 1-4) [CONFIDENTIAL] filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 03/28/2025) (2) |
| Mar 28, 2025 | 165 | NOTICE OF SERVICE of Defendant Cipla Limited's First Set of Supplemental Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-5) filed by Cipla Limited.(Taylor, Daniel) (Entered: 03/28/2025) (2) |
| Mar 27, 2025 | 162 | NOTICE OF SERVICE of Defendant Cipla Limited's Notice of Subpoenas to Curia Global, Inc. filed by Cipla Limited.(Taylor, Daniel) (Entered: 03/27/2025) (2) |
| Mar 27, 2025 | 163 | NOTICE to Take Deposition of Dr. Arjit Das on April 3, 2025 filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 03/27/2025) (3) |
| Mar 26, 2025 | 160 | NOTICE to Take Deposition of Dr. Bhaskar Reddy on April 17, 2025 filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 03/26/2025) (3) |
| Mar 26, 2025 | 161 | NOTICE to Take Deposition of Praveen Kumar on April 24, 2025 filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 03/26/2025) (3) |
| Mar 24, 2025 | 159 | NOTICE to Take Deposition of Mr. Venkatesh Murugan on April 3, 2025 filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 03/24/2025) (4) |
| Mar 5, 2025 | 157 | NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories to Defendant Aurobindo Pharma Limited (Nos. 3-6) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 03/05/2025) (3) |
| Mar 5, 2025 | 158 | NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories to Defendant Dexcel Pharma Technologies Limited (Nos. 2-5) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 03/05/2025) (3) |
| Feb 28, 2025 | 156 | NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to All Defendants (Nos. 1-6) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 02/28/2025) (5) |
| Feb 27, 2025 | 155 | NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendants' First Set of Joint Requests for Admission (Nos. 1-3); and (2) Plaintiffs' Responses and Objections to Defendants' Second Set of Common Interrogatories (Nos. 4-8) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 02/27/2025) (5) |
| Feb 26, 2025 | 154 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Hikma (Nos. 1-4); and (2) Plaintiffs' First Set of Requests for Admission to Hikma (Nos. 1-8) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 02/26/2025) (3) |
| Feb 25, 2025 | 153 | NOTICE of Withdrawal of Louis H. Weinstein as pro hac vice counsel for Defendant Cipla Limited by Cipla Limited (Taylor, Daniel) (Entered: 02/25/2025) (1) |
| Feb 24, 2025 | 152 | NOTICE to Take Deposition of Evan T. Powers, Ph.D. on March 7, 2025 filed by Aurobindo Pharma Limited.(Myer, R.) (Entered: 02/24/2025) (2) |
| Feb 21, 2025 | 151 | STIPULATION TO EXTEND TIME for certain deadlines in the Scheduling Order (D.I. 22, amended by D.I. 119) to dates as outlined in stipulation - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute. (Dellinger, Megan) (Entered: 02/21/2025) (3) |
| Feb 20, 2025 | 146 | NOTICE of Withdrawal of Attorney Jennifer P. Siew by Dexcel Pharma Technologies Limited (Siew, Jennifer) (Entered: 02/20/2025) (3) |
| Feb 20, 2025 | 147 | NOTICE of Appearance by Daniel G. Mackrides on behalf of Dexcel Pharma Technologies Limited (Mackrides, Daniel) (Entered: 02/20/2025) (2) |
| Feb 20, 2025 | 148 | NOTICE of Withdrawal of Samantha G. Wilson by Dexcel Pharma Technologies Limited (Gaza, Anne) (Entered: 02/20/2025) (3) |
| Feb 20, 2025 | 149 | NOTICE to Take Deposition of Hans Edward Purkey on March 9, 2025 filed by Dexcel Pharma Technologies Limited.(Mackrides, Daniel) (Entered: 02/20/2025) (3) |
| Feb 20, 2025 | 150 | NOTICE to Take Deposition of Jeffery W. Kelly on March 5, 2025 filed by Dexcel Pharma Technologies Limited.(Mackrides, Daniel) (Entered: 02/20/2025) (3) |
| Feb 18, 2025 | 145 | NOTICE to Take Deposition of Evan T. Powers, Ph.D. on March 7, 2025 filed by Aurobindo Pharma Limited.(Myer, R.) (Entered: 02/18/2025) (2) |
| Feb 14, 2025 | 144 | NOTICE OF SERVICE of (1)Plaintiffs' Responses and Objections to Dexcel's Notices of Rule 30(b)(6) Depositions; and (2) Plaintiffs' First Supplemental Objections and Responses to Dexcel Pharma Technologies Limited's First Set of Interrogatories (Nos. 1-3) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 02/14/2025) (3) |
| Feb 7, 2025 | 142 | NOTICE OF SERVICE of Plaintiffs' Second Supplemental Initial Disclosures Under Fed. R. Civ. P. 26(a)(1) - filed by Wyeth LLC, The Scripps Research Institute, Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V..(Dellinger, Megan) (Entered: 02/07/2025) (5) |
| Feb 7, 2025 | 143 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Dexcel's Second Set of Individual Requests for the Production of Documents and Things (Nos. 20-22) - filed by Wyeth LLC, The Scripps Research Institute, Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V..(Dellinger, Megan) (Entered: 02/07/2025) (3) |
| Feb 3, 2025 | 140 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Hikma's First Set of Requests for Admission (Nos. 1-6) - filed by Wyeth LLC, The Scripps Research Institute, Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V..(Dellinger, Megan) (Entered: 02/03/2025) (3) |
| Feb 3, 2025 | 141 | NOTICE to Take Deposition of Hossein Razavi on February 26, 2025 filed by Dexcel Pharma Technologies Limited.(Gaza, Anne) (Entered: 02/03/2025) (2) |
| Jan 31, 2025 | 137 | MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Mandernach - filed by Wyeth LLC, The Scripps Research Institute, Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V.. Motions referred to Christopher J. Burke.(Dellinger, Megan) (Entered: 01/31/2025) (5) |
| Jan 31, 2025 | 138 | Pro Hac Vice Fee - Credit Card Payment received for Christopher J. Mandernach. ( re 137 MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Mandernach )( Payment of $ 50, receipt number ADEDC-4604552).(Dellinger, Megan) (Entered: 01/31/2025) (0) |
| Jan 31, 2025 | 139 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Notice of Rule 30(b)(6) Depositions - filed by Wyeth LLC, The Scripps Research Institute, Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V..(Dellinger, Megan) (Entered: 01/31/2025) (5) |
| Jan 29, 2025 | 135 | NOTICE to Take Deposition of Hahdi Perfect on March 19, 2025 filed by Dexcel Pharma Technologies Limited.(Gaza, Anne) (Entered: 01/29/2025) (2) |
| Jan 29, 2025 | 136 | NOTICE OF SERVICE of 1) Notice of Rule 30(b)(6) Deposition of Pfizer, Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., and Wyeth LLC Pertaining to US Patent Nos. 7,214,695 and 7,214,696; and 2) Notice of Rule 30(b)(6) Deposition of the Scripps Research Institute Pertaining to US Patent Nos. 7,214,695 and 7,214,696 filed by Dexcel Pharma Technologies Limited.(Gaza, Anne) (Entered: 01/29/2025) (2) |
| Jan 28, 2025 | 130 | NOTICE to Take Deposition of Andrew Jensen on February 12, 2025 filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 01/28/2025) (2) |
| Jan 28, 2025 | 131 | NOTICE to Take Deposition of Heather Frericks Schmidt filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 01/28/2025) (2) |
| Jan 28, 2025 | 132 | NOTICE to Take Deposition of Kalpidev Arora on March 14, 2025 filed by Cipla Limited.(Taylor, Daniel) (Entered: 01/28/2025) (2) |
| Jan 28, 2025 | 133 | NOTICE to Take Deposition of Kris Jones on February 5, 2025 filed by Cipla Limited.(Taylor, Daniel) (Entered: 01/28/2025) (2) |
| Jan 28, 2025 | 134 | NOTICE to Take Deposition of Kevin Paul Girard on February 7, 2025 filed by Dexcel Pharma Technologies Limited.(Gaza, Anne) (Entered: 01/28/2025) (2) |
| Jan 17, 2025 | 129 | NOTICE OF SERVICE of Cipla Limited's Objections and Responses to Plaintiffs' Rule 30(b)(6) Notice of Deposition filed by Cipla Limited.(Taylor, Daniel) (Entered: 01/17/2025) (2) |
| Jan 16, 2025 | 128 | NOTICE OF SERVICE of Defendants Dexcel Pharma Technologies Limited, Cipla Limited, Hikma Pharmaceuticals USA Inc., and Aurobindo Pharma Limited's 30(b)(6) Notice of Deposition filed by Cipla Limited.(Taylor, Daniel) (Entered: 01/16/2025) (2) |
| Jan 14, 2025 | 125 | NOTICE OF SERVICE of Defendant Dexcel Pharma Technologies Limited's Second Set of Individual Requests for the Production of Documents and Things (Nos. 20-22) filed by Dexcel Pharma Technologies Limited.(Gaza, Anne) (Entered: 01/14/2025) (2) |
| Jan 14, 2025 | 126 | NOTICE OF SERVICE of (i) Defendants' Second Set of Common Interrogatories to Plaintiffs (Nos. 4-8), and (ii) Defendants' First Set of Joint Requests for Admission (Nos. 1-3) filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 01/14/2025) (2) |
| Jan 14, 2025 | 127 | NOTICE OF SERVICE of (i) Zenara's Answers and Objections to Plaintiffs' Notice of Rule 30(b)(6) Deposition of Zenara [Confidential], and (ii) Hikma's Answers and Objections to Plaintiffs' Notice of Rule 30(b)(6) Deposition of Hikma [Confidential] filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 01/14/2025) (2) |
| Jan 13, 2025 | 124 | NOTICE OF SERVICE of Defendant Hikma Pharmaceutical USA, Inc.'s Response to Plaintiffs' First Set of Requests for Production to Hikma (Nos. 1-40) filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 01/13/2025) (2) |
| Jan 3, 2025 | 123 | NOTICE OF SERVICE of Defendant Hikma Pharmaceutical USA, Inc.'s First Set of Requests for Admissions to Plaintiffs (Nos. 1-6) [CONFIDENTIAL] filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 01/03/2025) (2) |
| Dec 30, 2024 | 122 | ORAL ORDER: The Court, having reviewed the parties' proposed stipulation, (D.I. 119 ), and having discussed it with the District Judge, hereby ORDERS that the Court will alter and extend the deadlines for completion of fact and expert discovery and the filing of Daubert motions, as the parties request. But the parties should note that the District Judge has advised that any further stipulations regarding extensions to the deadline for filing Daubert motions will result in vacation of the operative pretrial conference and trial dates. Ordered by Judge Christopher J. Burke on 12/30/2024. (smg) Modified on 12/31/2024 (smg). (Entered: 12/30/2024) (0) |
| Dec 23, 2024 | 119 | STIPULATION TO EXTEND TIME for certain deadlines to dates as outlined in stipulation - filed by Wyeth LLC, The Scripps Research Institute, Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V.. (Dellinger, Megan) (Entered: 12/23/2024) (3) |
| Dec 23, 2024 | 120 | AFFIDAVIT of Service of Deposition Subpoena on Evotec (US) Inc. filed by Cipla Limited. (Taylor, Daniel) (Entered: 12/23/2024) (2) |
| Dec 23, 2024 | 121 | AFFIDAVIT of Service of Document Subpoena on Evotec (US) Inc. filed by Cipla Limited. (Taylor, Daniel) (Entered: 12/23/2024) (2) |
| Dec 12, 2024 | 117 | NOTICE OF SERVICE of Notice of Rule 30(b)(6) Deposition of Cipla filed by Wyeth LLC, The Scripps Research Institute, Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V..(Dellinger, Megan) (Entered: 12/12/2024) (3) |
| Dec 12, 2024 | 118 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Production to Hikma (Nos. 1-40); (2) Notice of Rule 30(b)(6) Deposition of Hikma; and (3) Notice of Rule 30(b)(6) Deposition of Zenara filed by Wyeth LLC, The Scripps Research Institute, Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V..(Dellinger, Megan) (Entered: 12/12/2024) (3) |
| Nov 25, 2024 | 114 | NOTICE of of Withdrawal of Counsel for Aurobindo Pharma Limited by Aurobindo Pharma Limited (Hitch, Cortlan) (Entered: 11/25/2024) (2) |
| Nov 25, 2024 | 115 | MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, George J. Barry, III, Michael P. Hogan, and John Thallemer - filed by Aurobindo Pharma Limited. Motions referred to Christopher J. Burke.(Myer, R.) (Entered: 11/25/2024) (5) |
| Nov 25, 2024 | 116 | Pro Hac Vice Fee - Credit Card Payment received for Timothy H. Kratz, George J. Barry, III, Michael P. Hogan, and John Thallemer. ( re 115 MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, George J. Barry, III, Michael P. Hogan, and John Thallemer )( Payment of $ 200, receipt number ADEDC-4556991).(Myer, R.) (Entered: 11/25/2024) (0) |
| Nov 22, 2024 | 113 | NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Limited (Myer, R.) (Entered: 11/22/2024) (1) |
| Nov 8, 2024 | 112 | NOTICE OF SERVICE of Non-Party Hans Purkey's Responses and Objections to Defendant Dexcel Pharma Technologies Limited's Subpoena Duces Tecum to Hans Edward Purkey - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 11/08/2024) (3) |
| Nov 7, 2024 | 111 | [SEALED] STIPULATION and [Proposed] Order of Infringement by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) Modified on 11/8/2024(smg). (Entered: 11/07/2024) (0) |
| Nov 6, 2024 | 110 | NOTICE OF SERVICE of (i) Defendant Hikma Pharmaceutical USA, Inc.'s Disclosures Pursuant to Delaware Default Standard Paragraph 3, and (ii) Amended Rule 26 Initial Disclosures of Defendant Hikma Pharmaceuticals USA, Inc. filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 11/06/2024) (2) |
| Oct 29, 2024 | 109 | NOTICE OF SERVICE of Aurobindo and Dexcel's Supplemental Initial Invalidity Contentions for U.S. Patent Nos. 7,214,695 and 7,214,696 filed by Aurobindo Pharma Limited.(Dorsney, Kenneth) (Entered: 10/29/2024) (2) |
| Oct 25, 2024 | 108 | NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses and Objections to Defendants' First Set of Collective Interrogatories (Nos. 1-3) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 10/25/2024) (5) |
| Oct 22, 2024 | 107 | NOTICE of Subpoena and Deposition to Hans Edward Purkey by Dexcel Pharma Technologies Limited (Wilson, Samantha) (Entered: 10/22/2024) (30) |
| Oct 16, 2024 | 106 | Letter to The Honorable Christopher J. Burke from Megan E. Dellinger regarding interim status report - re 22 Scheduling Order. (Dellinger, Megan) Modified on 10/16/2024 (smg). (Entered: 10/16/2024) (2) |
| Oct 11, 2024 | 105 | STIPULATION to Substitute Hikma Pharmaceuticals USA Inc. for Zenara Pharma Private Limited by Zenara Pharma Private Limited. (Gattuso, Dominick) (Entered: 10/11/2024) (6) |
| Sep 27, 2024 | 103 | NOTICE OF SERVICE of Plaintiffs' Supplemental Disclosure of Asserted Claims and Infringement Contentions for Aurobindo's ANDA Products filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 09/27/2024) (3) |
| Sep 27, 2024 | 104 | NOTICE OF SERVICE of Plaintiffs' Supplemental Initial Disclosures Under Fed. R. Civ. P. 26(a)(1) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 09/27/2024) (5) |
| Sep 24, 2024 | 102 | NOTICE OF SERVICE of Defendant Aurobindo Pharma Limited's Second Amended 26(a) and Paragraph 3 Disclosures filed by Aurobindo Pharma Limited.(Dorsney, Kenneth) (Entered: 09/24/2024) (2) |
| Sep 3, 2024 | 100 | NOTICE OF SERVICE of Plaintiffs' Supplemental Disclosure of Asserted Claims and Infringement Contentions for Zenara's ANDA Product filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 09/03/2024) (3) |
| Sep 3, 2024 | 101 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Dexcel and Aurobindo's First Set of Common Requests for the Production of Documents and Things (Nos. 1-7) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 09/03/2024) (4) |
| Aug 20, 2024 | 99 | Amended STIPULATION Stipulation and [PROPOSED] Order Further Amending the Scheduling Order re 22 Scheduling Order,,,,, by Zenara Pharma Private Limited. (Gattuso, Dominick) (Entered: 08/20/2024) (4) |
| Aug 2, 2024 | 98 | NOTICE OF SERVICE of Defendants Aurobindo and Dexcel's First Set of Common Requests for Production to Plaintiffs (Nos. 1-7) filed by Aurobindo Pharma Limited.(Dorsney, Kenneth) (Entered: 08/02/2024) (2) |
| Jul 22, 2024 | 97 | NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Dexcel's First Set of Individual Requests for the Production of Documents and Things (Nos. 1- 19); and (2) Plaintiffs' Objections and Responses to Dexcel Pharma Technologies Limited's First Set of Interrogatories (Nos. 1-3) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 07/22/2024) (3) |
| Jul 19, 2024 | 96 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' First Set of Common Requests for the Production of Documents and Things (Nos. 1-141) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 07/19/2024) (5) |
| Jul 17, 2024 | 95 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Collective Interrogatories (Nos. 1-3) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 07/17/2024) (5) |
| Jul 15, 2024 | 94 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Zenara's First Set of Interrogatories (No. 1); and (2) Plaintiffs' Responses and Objections to Zenara's First Set of Requests for the Production of Documents and Things (No. 1) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 07/15/2024) (3) |
| Jun 4, 2024 | 93 | NOTICE OF SERVICE of Defendant Dexcel Pharma Technologies Limited's Supplemental Response and Objections to Plaintiffs' First Set of Interrogatories (No. 1) filed by Dexcel Pharma Technologies Limited.(Wilson, Samantha) (Entered: 06/04/2024) (2) |
| May 22, 2024 | 92 | NOTICE OF SERVICE of 1) Defendant Dexcel Pharma Technologies Limited's First Set of Individual Requests for the Production of Documents and Things (Nos. 1-19); and 2) Defendant Dexcel Pharma Technologies Limited's First Set of Individual Interrogatories (Nos. 1-3) filed by Dexcel Pharma Technologies Limited.(Wilson, Samantha) (Entered: 05/22/2024) (2) |
| May 20, 2024 | N/A | SO ORDERED, re 83 MOTION for Pro Hac Vice Appearance of Attorney Ayelet Evrony filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute, 81 MOTION for Pro Hac Vice Appearance of Attorney Charles K. Shih of Neal Gerber & Eisenberg LLP filed by Zenara Pharma Private Limited. Ordered by Judge Christopher J. Burke on 05/20/2024. (smg) (Entered: 05/20/2024) (0) |
| May 20, 2024 | 89 | Letter to The Honorable Christopher J. Burke from Megan E. Dellinger regarding request to cancel October 2, 2024 Markman hearing. (Dellinger, Megan) (Entered: 05/20/2024) (1) |
| May 20, 2024 | 90 | NOTICE OF SERVICE of Defendants' First Set of Common Requests for the Production of Documents and Things to Plaintiffs (Nos. 1-141) [CONFIDENTIAL] filed by Zenara Pharma Private Limited.(Gattuso, Dominick) (Entered: 05/20/2024) (2) |
| May 20, 2024 | 91 | ORAL ORDER: The Court, having reviewed the parties’ May 20, 2024 letter requesting that the Court cancel the Markman hearing scheduled for October 2, 2024, (D.I. 89 ), hereby ORDERS that the parties’ request is GRANTED. The Markman hearing is CANCELED, and the deadlines for the associated briefing and technology tutorials are removed from the calendar, (D.I. 22 at paras. 11-13). Ordered by Judge Christopher J. Burke on 05/20/2024. (smg) (Entered: 05/21/2024) (0) |
| May 17, 2024 | 83 | MOTION for Pro Hac Vice Appearance of Attorney Ayelet Evrony - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. Motions referred to Christopher J. Burke.(Dellinger, Megan) (Entered: 05/17/2024) (5) |
| May 17, 2024 | 84 | Pro Hac Vice Fee - Credit Card Payment received for Ayelet Evrony. ( re 83 MOTION for Pro Hac Vice Appearance of Attorney Ayelet Evrony )( Payment of $ 50, receipt number ADEDC-4409702).(Dellinger, Megan) (Entered: 05/17/2024) (0) |
| May 17, 2024 | 85 | NOTICE OF SERVICE of Defendants Aurobindo Pharma Limited, Zenara Pharma Private Limited, Cipla Limited, and Dexcel Pharma Technologies Limited's First Set of Confidential Collective Interrogatories (Nos. 1-3) filed by Cipla Limited.(Taylor, Daniel) (Entered: 05/17/2024) (2) |
| May 17, 2024 | 86 | REDACTED VERSION of 71 Unopposed MOTION for Issuance of Letters Rogatory (No. 2) by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Attachments: # 1 Exhibit A)(Megan Dellinger) Modified on 5/17/2024 to reflect correct attorney. (mrr). (Entered: 05/17/2024) (0) |
| May 17, 2024 | 87 | REDACTED VERSION of 72 Unopposed MOTION for Issuance of Letters Rogatory (No. 3) by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Attachments: # 1 Exhibit A)(Dellinger, Megan) (Entered: 05/17/2024) (0) |
| May 17, 2024 | 88 | REDACTED VERSION of 70 Unopposed MOTION for Issuance of Letters Rogatory (No. 1) by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Attachments: # 1 Exhibit A)(Dellinger, Megan) (Entered: 05/17/2024) (0) |
| May 16, 2024 | 81 | MOTION for Pro Hac Vice Appearance of Attorney Charles K. Shih of Neal Gerber & Eisenberg LLP - filed by Zenara Pharma Private Limited. Motions referred to Christopher J. Burke.(Gattuso, Dominick) (Entered: 05/16/2024) (3) |
| May 16, 2024 | 82 | Pro Hac Vice Fee - Credit Card Payment received for Charles K. Shih of Neal Gerber & Eisenberg LLP. ( re 81 MOTION for Pro Hac Vice Appearance of Attorney Charles K. Shih of Neal Gerber & Eisenberg LLP )( Payment of $ 50, receipt number ADEDC-4409161).(Gattuso, Dominick) (Entered: 05/16/2024) (0) |
| May 15, 2024 | 80 | NOTICE OF SERVICE of (i) Zenara's First Set of Requests for the Production of Documents and Things to Plaintiffs [CONFIDENTIAL]; and, (ii) Zenara's First Set of Interrogatories to Plaintiffs (No. 1) [CONFIDENTIAL] filed by Zenara Pharma Private Limited.(Gattuso, Dominick) (Entered: 05/15/2024) (2) |
| May 13, 2024 | 73 | [SEALED] ORDER GRANTING D.I. 70 Unopposed MOTION for Issuance of Letters Rogatory (No. 1) filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc. Signed by Judge Christopher J. Burke on 05/13/2024.This order has been emailed to local counsel. (smg) (Entered: 05/13/2024) (0) |
| May 13, 2024 | 74 | [SEALED] REQUEST for International Judicial Assistance Pursuant to the Hague Convention. Signed by Judge Christopher J. Burke on 05/13/2024.This order has been emailed to local counsel. (smg) (Entered: 05/13/2024) (0) |
| May 13, 2024 | 75 | [SEALED] ORDER GRANTING D.I. 71 Unopposed MOTION for Issuance of Letters Rogatory (No. 2) filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc. Signed by Judge Christopher J. Burke on 05/13/2024.This order has been emailed to local counsel. (smg) (Entered: 05/13/2024) (0) |
| May 13, 2024 | 76 | [SEALED] REQUEST for International Judicial Assistance Pursuant to the Hague Convention. Signed by Judge Christopher J. Burke on 05/13/2024.This order has been emailed to local counsel. (smg) (Entered: 05/13/2024) (0) |
| May 13, 2024 | 77 | [SEALED] ORDER GRANTING D.I. 72 Unopposed MOTION for Issuance of Letters Rogatory (No. 3) filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc. Signed by Judge Christopher J. Burke on 05/13/2024.This order has been emailed to local counsel. (smg) (Entered: 05/13/2024) (0) |
| May 13, 2024 | 78 | [SEALED] REQUEST for International Judicial Assistance Pursuant to the Hague Convention. Signed by Judge Christopher J. Burke on 05/13/2024.This order has been emailed to local counsel. (smg) (Entered: 05/13/2024) (0) |
| May 13, 2024 | N/A | Remark: Certified copies of D.I. 74 , 76 , and 78 Letters of Request available for pickup by plaintiffs counsel at the Clerk's Office from 8:30am-4pm Monday - Friday. (smg) (Entered: 05/13/2024) (0) |
| May 13, 2024 | 79 | NOTICE of Appearance by Neal C. Belgam on behalf of Cipla Limited (Belgam, Neal) (Entered: 05/13/2024) (1) |
| May 10, 2024 | 70 | [SEALED] Unopposed MOTION for Issuance of Letters Rogatory (No. 1) - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., Wyeth LLC. (Attachments: # 1 Exhibit A)(Dellinger, Megan) (Entered: 05/10/2024) (0) |
| May 10, 2024 | 71 | [SEALED] Unopposed MOTION for Issuance of Letters Rogatory (No. 2) - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., Wyeth LLC. (Attachments: # 1 Exhibit A)(Dellinger, Megan) (Entered: 05/10/2024) (0) |
| May 10, 2024 | 72 | [SEALED] Unopposed MOTION for Issuance of Letters Rogatory (No. 3) - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., Wyeth LLC. (Attachments: # 1 Exhibit A)(Dellinger, Megan) (Entered: 05/10/2024) (0) |
| May 10, 2024 | N/A | MOTION REFERRED: D.I. 70 Unopposed MOTION for Issuance of Letters Rogatory (No. 1), D.I. 71 Unopposed MOTION for Issuance of Letters Rogatory (No. 2), and D.I. 72 Unopposed MOTION for Issuance of Letters Rogatory (No. 3). Motions referred to Christopher J. Burke.(smg) (Entered: 05/13/2024) (0) |
| May 3, 2024 | 66 | NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions for U.S. Patent No. 9,770,441. filed by Dexcel Pharma Technologies Limited.(Wilson, Samantha) (Entered: 05/03/2024) (2) |
| May 3, 2024 | 67 | NOTICE OF SERVICE of Defendants Aurobindo and Dexcel's Initial Invalidity Contentions for U.S. Patent Nos. 7,214,695 and 7,214,696. filed by Dexcel Pharma Technologies Limited.(Wilson, Samantha) (Entered: 05/03/2024) (2) |
| May 3, 2024 | 68 | NOTICE OF SERVICE of Defendants' Disclosure Pursuant to Paragraph 12 of the Scheduling Order Regarding Claim Terms for Construction filed by Dexcel Pharma Technologies Limited.(Wilson, Samantha) (Entered: 05/03/2024) (2) |
| May 3, 2024 | 69 | NOTICE OF SERVICE of Plaintiffs' Proposed Claim Terms for Construction filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 05/03/2024) (5) |
| Apr 25, 2024 | 65 | NOTICE of Withdrawal of Counsel for Zenara Pharma Private Limited by Zenara Pharma Private Limited (Dorsney, Kenneth) (Entered: 04/25/2024) (2) |
| Apr 22, 2024 | N/A | Pro Hac Vice Attorney Jeffrey S. Ward for Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 04/22/2024) (0) |
| Apr 19, 2024 | N/A | SO ORDERED D.I. 64 STIPULATION TO EXTEND TIME of various deadlines in the Scheduling Order D.I. 22 to filed by Cipla Limited. Ordered by Judge Christopher J. Burke on 4/19/2024. (dlb) (Entered: 04/19/2024) (0) |
| Apr 18, 2024 | N/A | SO ORDERED D.I. 62 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey S. Ward and Emer L. Simic of Neal Gerber & Eisenberg LLP filed by Zenara Pharma Private Limited. Ordered by Judge Christopher J. Burke on 4/18/2024. (dlb) (Entered: 04/18/2024) (0) |
| Apr 18, 2024 | 64 | STIPULATION TO EXTEND TIME of various deadlines in the Scheduling Order D.I. 22 to - filed by Cipla Limited. (Taylor, Daniel) (Entered: 04/18/2024) (3) |
| Apr 17, 2024 | 62 | MOTION for Pro Hac Vice Appearance of Attorney Jeffrey S. Ward and Emer L. Simic of Neal Gerber & Eisenberg LLP - filed by Zenara Pharma Private Limited. Motions referred to Christopher J. Burke.(Gattuso, Dominick) (Entered: 04/17/2024) (4) |
| Apr 17, 2024 | 63 | Pro Hac Vice Fee - Credit Card Payment received for Jeffrey S. Ward and Emer L. Simic. ( re 62 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey S. Ward and Emer L. Simic of Neal Gerber & Eisenberg LLP )( Payment of $ 100, receipt number ADEDC-4386583).(Gattuso, Dominick) (Entered: 04/17/2024) (0) |
| Apr 16, 2024 | 61 | NOTICE of Appearance by Dominick T. Gattuso on behalf of Zenara Pharma Private Limited (Gattuso, Dominick) (Entered: 04/16/2024) (1) |
| Apr 4, 2024 | 60 | STIPULATION TO EXTEND TIME to various deadlines in the Scheduling Order D.I. 22 - filed by Cipla Limited. (Taylor, Daniel) (Entered: 04/04/2024) (3) |
| Apr 4, 2024 | N/A | SO ORDERED D.I. 60 STIPULATION TO EXTEND TIME to various deadlines in the Scheduling Order D.I. 22 filed by Cipla Limited. So Ordered by Judge Christopher J. Burke on 4/4/2024. (dlb) (Entered: 04/04/2024) (0) |
| Apr 1, 2024 | 57 | NOTICE OF SERVICE of (1) Aurobindo's response to Plaintiffs' First Set of Interrogatories (Nos. 1-2); and (2) Zenara's response to Plaintiffs' First Set of Interrogatories (Nos. 1-5) filed by Aurobindo Pharma Limited, Zenara Pharma Private Limited.(Dorsney, Kenneth) (Entered: 04/01/2024) (2) |
| Apr 1, 2024 | 58 | NOTICE OF SERVICE of Defendant Dexcel Pharma Technologies Limited's Responses and Objections to Plaintiffs' First Set of Interrogatories (No. 1) filed by Dexcel Pharma Technologies Limited.(Wilson, Samantha) (Entered: 04/01/2024) (2) |
| Apr 1, 2024 | 59 | NOTICE OF SERVICE of Defendant Cipla Limited's Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-5) filed by Cipla Limited.(Taylor, Daniel) (Entered: 04/01/2024) (2) |
| Mar 25, 2024 | 56 | NOTICE OF SERVICE of Defendant Cipla Limited's Responses and Objections to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-78) filed by Cipla Limited.(Taylor, Daniel) (Entered: 03/25/2024) (2) |
| Mar 13, 2024 | 55 | NOTICE OF SERVICE of Aurobindo's First Amended 26(a) and Paragraph 3 Disclosures filed by Aurobindo Pharma Limited.(Dorsney, Kenneth) (Entered: 03/13/2024) (2) |
| Mar 11, 2024 | 53 | NOTICE OF SERVICE of (1) Aurobindo's response to Plaintiffs' First Set of Requests for Production (Nos. 1-46); and (2) Zenara's response to Plaintiffs' First Set of Requests for Production (Nos. 1-79) filed by Aurobindo Pharma Limited, Zenara Pharma Private Limited.(Dorsney, Kenneth) (Entered: 03/11/2024) (2) |
| Mar 11, 2024 | 54 | NOTICE OF SERVICE of Defendant Dexcel Pharma Technologies Limited's Responses and Objections to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-23) filed by Dexcel Pharma Technologies Limited.(Wilson, Samantha) (Entered: 03/11/2024) (2) |
| Mar 4, 2024 | 52 | ORAL ORDER: The Court notes that since the scheduling order was entered in this case, (D.I. 22), the Court has changed its policies regarding when parties must file their motions for claim construction and now requires parties to file their motions for claim construction concurrently with the Joint Claim Construction Brief. See Judge Burke's "Rule 16 Scheduling Order--Patent" found on Judge Burke's portion of the District Court's website. In light of this, the Court hereby ORDERS that the parties shall file their motions for claim construction concurrently with the Joint Claim Construction Brief. Ordered by Judge Christopher J. Burke on 3/4/2024. (dlb) (Entered: 03/04/2024) (0) |
| Feb 28, 2024 | 51 | NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories (Separate Sets for Each Defendant Group) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 02/28/2024) (6) |
| Feb 23, 2024 | N/A | SO ORDERED D.I. 49 MOTION for Pro Hac Vice Appearance of Attorney Andrew L. Hoffman and Max Accardi filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Ordered by Judge Christopher J. Burke on 2/23/2024. (dlb) (Entered: 02/23/2024) (0) |
| Feb 22, 2024 | 49 | MOTION for Pro Hac Vice Appearance of Attorney Andrew L. Hoffman and Max Accardi - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. Motions referred to Christopher J. Burke.(Dellinger, Megan) (Entered: 02/22/2024) (7) |
| Feb 22, 2024 | 50 | Pro Hac Vice Fee - Credit Card Payment received for Andrew L. Hoffman and Max Accardi. ( re 49 MOTION for Pro Hac Vice Appearance of Attorney Andrew L. Hoffman and Max Accardi )( Payment of $ 100, receipt number ADEDC-4345302).(Dellinger, Megan) (Entered: 02/22/2024) (0) |
| Feb 21, 2024 | N/A | SO ORDERED D.I. 47 MOTION for Pro Hac Vice Appearance of Attorney Christopher M. Gallo filed by Dexcel Pharma Technologies Limited. Ordered by Judge Christopher J. Burke on 2/21/2024. (dlb) (Entered: 02/21/2024) (0) |
| Feb 16, 2024 | 47 | MOTION for Pro Hac Vice Appearance of Attorney Christopher M. Gallo - filed by Dexcel Pharma Technologies Limited. Motions referred to Christopher J. Burke.(Wilson, Samantha) (Entered: 02/16/2024) (4) |
| Feb 16, 2024 | 48 | Pro Hac Vice Fee - Credit Card Payment received for Christopher M. Gallo. ( re 47 MOTION for Pro Hac Vice Appearance of Attorney Christopher M. Gallo )( Payment of $ 50, receipt number ADEDC-4341429).(Wilson, Samantha) (Entered: 02/16/2024) (0) |
| Feb 14, 2024 | N/A | Pro Hac Vice Attorneys Amlan Ray and Frank D. Rodriguez for Cipla Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/14/2024) (0) |
| Feb 9, 2024 | 43 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production to Aurobindo (Nos. 1-46) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 02/09/2024) (3) |
| Feb 9, 2024 | 44 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production to Cipla (Nos. 1-78) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 02/09/2024) (3) |
| Feb 9, 2024 | 45 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production to Dexcel (Nos. 1-23) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 02/09/2024) (3) |
| Feb 9, 2024 | 46 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production to Zenara (Nos. 1-79) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 02/09/2024) (3) |
| Feb 7, 2024 | N/A | SO ORDERED D.I. 41 MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez and Amlan Ray filed by Cipla Limited. Ordered by Judge Christopher J. Burke on 2/7/2024. (dlb) (Entered: 02/07/2024) (0) |
| Feb 6, 2024 | 41 | MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez and Amlan Ray - filed by Cipla Limited. Motions referred to Christopher J. Burke.(Taylor, Daniel) (Entered: 02/06/2024) (4) |
| Feb 6, 2024 | 42 | Pro Hac Vice Fee - Credit Card Payment received for Frank D. Rodriguez and Amlan Ray. ( re 41 MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez and Amlan Ray )( Payment of $ 100, receipt number ADEDC-4331503).(Taylor, Daniel) (Entered: 02/06/2024) (0) |
| Feb 2, 2024 | 40 | NOTICE OF SERVICE of Plaintiffs' Disclosure of Asserted Claims and Infringement Contentions (Separate Sets for Each Defendant Group) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 02/02/2024) (5) |
| Jan 26, 2024 | N/A | SO ORDERED D.I. 38 Stipulation of Infringement as to Dexcel Pharma Technologies Limited. Ordered by Judge Christopher J. Burke on 1/26/2024. (dlb) (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 39 | NOTICE OF SERVICE of Dexcel Pharma Technologies Limited's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Dexcel Pharma Technologies Limited.(Wilson, Samantha) (Entered: 01/26/2024) (2) |
| Jan 25, 2024 | 38 | STIPULATION and [Proposed] Order of Infringement as to Dexcel Pharma Technologies Limited by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 01/25/2024) (3) |
| Jan 12, 2024 | 36 | STIPULATION TO EXTEND TIME for Dexcel to serve its core technical documents, to produce samples of its ANDA products, and to serve its disclosures pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information to January 26, 2024 - filed by Dexcel Pharma Technologies Limited. (Wilson, Samantha) (Entered: 01/12/2024) (2) |
| Jan 12, 2024 | N/A | SO ORDERED D.I. 36 STIPULATION TO EXTEND TIME for Dexcel to serve its core technical documents, to produce samples of its ANDA products, and to serve its disclosures pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Sto filed by Dexcel Pharma Technologies Limited. Ordered by Judge Christopher J. Burke on 1/12/2024. (dlb) (Entered: 01/12/2024) (0) |
| Jan 12, 2024 | 37 | NOTICE OF SERVICE of Defendant Cipla Limited's Initial Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Cipla Limited.(Taylor, Daniel) (Entered: 01/12/2024) (2) |
| Jan 3, 2024 | N/A | SO ORDERED D.I. 35 STIPULATION TO EXTEND TIME for Defendants Aurobindo and Zenara to produce samples to January 12, 2024 filed by Aurobindo Pharma Limited, Zenara Pharma Private Limited. Ordered by Judge Christopher J. Burke on 1/3/2024. (mlc) (Entered: 01/03/2024) (0) |
| Dec 22, 2023 | 35 | STIPULATION TO EXTEND TIME for Defendants Aurobindo and Zenara to produce samples to January 12, 2024 - filed by Aurobindo Pharma Limited, Zenara Pharma Private Limited. (Dorsney, Kenneth) (Entered: 12/22/2023) (2) |
| Dec 21, 2023 | 34 | STIPULATION TO EXTEND TIME for Defendant Cipla Limited's disclosures pursuant to Paragraph 3 of the Delaware Default standard be extended from December 27, 2023 to January 12, 2024 - filed by Cipla Limited. (Taylor, Daniel) (Entered: 12/21/2023) (2) |
| Dec 21, 2023 | N/A | SO ORDERED D.I. 34 STIPULATION TO EXTEND TIME for Defendant Cipla Limited's disclosures pursuant to Paragraph 3 of the Delaware Default standard be extended from December 27, 2023 to January 12, 2024 filed by Cipla Limited. Ordered by Judge Christopher J. Burke on 12/21/2023. (dlb) (Entered: 12/21/2023) (0) |
| Dec 20, 2023 | 33 | STIPULATION TO EXTEND TIME for Dexcel to serve its disclosures pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information to January 12, 2024 - filed by Dexcel Pharma Technologies Limited. (Wilson, Samantha) (Entered: 12/20/2023) (2) |
| Dec 20, 2023 | N/A | SO ORDERED D.I. 33 STIPULATION TO EXTEND TIME for Dexcel to serve its disclosures pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information to January 12, 2024 filed by Dexcel Pharma Technologies Limited. Ordered by Judge Christopher J. Burke on 12/20/2023. (dlb) (Entered: 12/20/2023) (0) |
| Dec 15, 2023 | 32 | STIPULATED PROTECTIVE ORDER. Signed by Judge Christopher J. Burke on 12/15/2023. (dlb) (Entered: 12/15/2023) (29) |
| Dec 14, 2023 | 30 | STIPULATION TO EXTEND TIME for Dexcel to serve Core Technical Documents and to Produce Samples of ANDA Products to January 12, 2024 - filed by Dexcel Pharma Technologies Limited. (Wilson, Samantha) (Entered: 12/14/2023) (2) |
| Dec 14, 2023 | N/A | SO ORDERED D.I. 30 STIPULATION TO EXTEND TIME for Dexcel to serve Core Technical Documents and to Produce Samples of ANDA Products to January 12, 2024 filed by Dexcel Pharma Technologies Limited. Ordered by Judge Christopher J. Burke on 12/14/2023. (dlb) (Entered: 12/14/2023) (0) |
| Dec 14, 2023 | 31 | PROPOSED ORDER -- Protective Order -- by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 12/14/2023) (29) |
| Dec 12, 2023 | N/A | SO ORDERED D.I. 29 MOTION for Pro Hac Vice Appearance of Attorney Rhochelle Krawetz filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Ordered by Judge Christopher J. Burke on 12/12/2023. (dlb) (Entered: 12/12/2023) (0) |
| Dec 11, 2023 | 29 | MOTION for Pro Hac Vice Appearance of Attorney Rhochelle Krawetz - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. Motions referred to Christopher J. Burke.(Dellinger, Megan) (Entered: 12/11/2023) (5) |
| Dec 8, 2023 | 28 | NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 12/08/2023) (5) |
| Dec 7, 2023 | 26 | STIPULATION TO EXTEND TIME for Cipla, Aurobindo, and Zenara to produce samples of their ANDA products to December 22, 2023 - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 12/07/2023) (2) |
| Dec 7, 2023 | 27 | STIPULATION TO EXTEND TIME for the parties to submit a [Proposed] Protective Order to December 14, 2023 - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 12/07/2023) (3) |
| Dec 7, 2023 | N/A | SO ORDERED D.I. 26 STIPULATION TO EXTEND TIME for Cipla, Aurobindo, and Zenara to produce samples of their ANDA products to December 22, 2023 filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Ordered by Judge Christopher J. Burke on 12/7/2023. (mlc) (Entered: 12/07/2023) (0) |
| Dec 7, 2023 | N/A | SO ORDERED D.I. 27 STIPULATION TO EXTEND TIME for the parties to submit a [Proposed] Protective Order to December 14, 2023 filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Ordered by Judge Christopher J. Burke on 12/7/2023. (mlc) (Entered: 12/07/2023) (0) |
| Dec 4, 2023 | N/A | SO ORDERED D.I. 23 Joint STIPULATION TO EXTEND TIME to PRODUCE Core Technical Documents & Samples to 12/15/2023 and 12/22/2023 filed by Dexcel Pharma Technologies Limited. Ordered by Judge Christopher J. Burke on 12/4/2023. (dlb) (Entered: 12/04/2023) (0) |
| Dec 4, 2023 | 24 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Under Fed. R. Civ. P. 26(a)(1) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 12/04/2023) (5) |
| Dec 4, 2023 | 25 | NOTICE OF SERVICE of Defendant Dexcel Pharma Technologies Limited's Rule 26(a)(1) Initial Disclosures filed by Dexcel Pharma Technologies Limited.(Gaza, Anne) (Entered: 12/04/2023) (2) |
| Dec 1, 2023 | 23 | Joint STIPULATION TO EXTEND TIME to PRODUCE Core Technical Documents & Samples to 12/15/2023 and 12/22/2023 - filed by Dexcel Pharma Technologies Limited. (Gaza, Anne) (Entered: 12/01/2023) (2) |
| Nov 27, 2023 | 22 | SCHEDULING ORDER: The five related captioned cases herein are consolidated for all purposes, including discovery and trial,and the provisions of this scheduling order shall govern in each case. Joinder of Parties due by 10/4/2024. Amended Pleadings due by 10/4/2024. Fact Discovery completed by 10/25/2024. Opening Expert Reports due by 1/24/2025. Rebuttal Expert Reports due by 4/25/2025. Reply Expert Reports due by 6/27/2025. Expert Discovery due by 9/12/2025. Status Report due by 9/4/2024. Claim Construction Opening Brief due by 6/21/2024. Claim Construction Answering Brief due by 7/19/2024. Claim Construction Reply Brief due by 8/2/2024. Claim Construction Surreply Brief due by 8/16/2024. Joint Claim Construction Brief due by 8/30/2024. A Markman Hearing is set for 10/2/2024 at 11:00 AM in Courtroom 2A before Judge Christopher J. Burke. A Pretrial Conference is set for 4/21/2026 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Bench Trial is set for 4/27/2026 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams.. Signed by Judge Christopher J. Burke on 11/27/2023. Associated Cases: 1:23-cv-00879-GBW-CJB, 1:23-cv-00909-GBW-CJB, 1:23-cv-00923-GBW-CJB, 1:23-cv-00924-GBW-CJB, 1:23-cv-01182-GBW-CJB(dlb) (Entered: 12/08/2023) (25) |
| Nov 27, 2023 | N/A | Pro Hac Vice Attorney Dmitry V. Shelhoff,Kenneth S. Canfield for Aurobindo Pharma Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dlb) (Entered: 04/19/2024) (0) |
| Nov 22, 2023 | N/A | Case Reassigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 11/22/2023) (0) |
| Nov 16, 2023 | 21 | Letter to The Honorable Christopher J. Burke from Megan E. Dellinger regarding Proposed Scheduling Order. (Attachments: # 1 Exhibits A-B)(Dellinger, Megan) (Entered: 11/16/2023) (0) |
| Nov 9, 2023 | 20 | NOTICE OF SERVICE of Plaintiffs' Identification of Accused Products and Asserted Patents Pursuant to Paragraph 4.a of the Delaware Default Standard for Discovery filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 11/09/2023) (6) |
| Nov 8, 2023 | 19 | STIPULATION TO EXTEND TIME for the parties to submit a proposed scheduling order, letter, and copy of the case management checklist pursuant to the Court's Order to November 16, 2023 - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 11/08/2023) (3) |
| Nov 8, 2023 | N/A | SO ORDERED D.I. (11 in 1:23-cv-01182-GBW-CJB, 18 in 1:23-cv-00924-GBW-CJB, 19 in 1:23-cv-00909-GBW-CJB, 19 in 1:23-cv-00879-JCG-CJB, 18 in 1:23-cv-00923-GBW-CJB) STIPULATION TO EXTEND TIME for the parties to submit a proposed scheduling order, letter, and copy of the case management checklist pursuant to the Court's Order to November 16, 2023 filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Ordered by Judge Christopher J. Burke on 11/8/2023. Associated Cases: 1:23-cv-00879-JCG-CJB, 1:23-cv-00909-GBW-CJB, 1:23-cv-00923-GBW-CJB, 1:23-cv-00924-GBW-CJB, 1:23-cv-01182-GBW-CJB(dlb) (Entered: 11/08/2023) (0) |
| Nov 3, 2023 | N/A | Case Reassigned to Judge Jennifer Choe-Groves of the United States Court of International Trade. Please include the initials of the Judge (JCG) after the case number on all documents filed. (nmg) (Entered: 11/03/2023) (0) |
| Oct 26, 2023 | 18 | Joint Letter to The Honorable Christopher J. Burke from Megan E. Dellinger regarding non-consent to magistrate judge jurisdiction - re (15 in 1:23-cv-00923-GBW-CJB, 15 in 1:23-cv-00924-GBW-CJB, 16 in 1:23-cv-00879-GBW-CJB, 16 in 1:23-cv-00909-GBW-CJB) Oral Order,,. (Dellinger, Megan) (Entered: 10/26/2023) (1) |
| Oct 25, 2023 | N/A | SO ORDERED D.I. Nos.(17 in 1:23-cv-00909-GBW-CJB, 16 in 1:23-cv-00923-GBW-CJB, 16 in 1:23-cv-00924-GBW-CJB, 17 in 1:23-cv-00879-GBW-CJB) STIPULATION TO EXTEND TIME for the parties to submit a proposed scheduling order, letter, and copy of the case management checklist pursuant to the Court's Order to November 9, 2023 filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Ordered by Judge Christopher J. Burke on 10/25/2023. Associated Cases: 1:23-cv-00879-GBW-CJB, 1:23-cv-00909-GBW-CJB, 1:23-cv-00923-GBW-CJB, 1:23-cv-00924-GBW-CJB(dlb) (Entered: 10/25/2023) (0) |
| Oct 24, 2023 | 17 | STIPULATION TO EXTEND TIME for the parties to submit a proposed scheduling order, letter, and copy of the case management checklist pursuant to the Court's Order to November 9, 2023 - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 10/24/2023) (3) |
| Oct 19, 2023 | 16 | ORAL ORDER: By no later than seven days from today's date, the parties shall meet and confer and submit a letter of no more than one single-spaced page indicating whether they would jointly agree to consent to Judge Burke's jurisdiction to conduct all proceedings in this case. To the extent the parties consent, the Court will work with them to ensure that it provides a final post-trial decision prior to expiration of the 30-month stay in a time frame that is acceptable to all parties. Ordered by Judge Christopher J. Burke on 10/19/2023. Associated Cases: 1:23-cv-00879-GBW-CJB, 1:23-cv-00909-GBW-CJB, 1:23-cv-00923-GBW-CJB, 1:23-cv-00924-GBW-CJB(dlb) (Entered: 10/19/2023) (0) |
| Oct 17, 2023 | N/A | Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burke's portion of the District Court's webpage: https://www.ded.uscourts.gov/sites/ded/files/CJBCC2022.pdf Associated Cases: 1:23-cv-00923-GBW-CJB, 1:23-cv-00879-GBW-CJB, 1:23-cv-00909-GBW-CJB, 1:23-cv-00924-GBW-CJB(dlb) (Entered: 10/17/2023) (0) |
| Oct 17, 2023 | N/A | REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf Associated Cases: 1:23-cv-00923-GBW-CJB, 1:23-cv-00879-GBW-CJB, 1:23-cv-00909-GBW-CJB, 1:23-cv-00924-GBW-CJB(dlb) (Entered: 10/17/2023) (0) |
| Oct 17, 2023 | 15 | ORAL ORDER: IT IS HEREBY ORDERED that by no later than October 26, 2023, the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burke's Case Management Checklist ("Checklist"), if applicable. By that date, the parties shall also jointly file the following: (i) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order that is consistent with Judge Burke's "Rule 16 Scheduling Order--Patent" (with alterations for ANDA cases) up through and including paragraph number 16 (i.e., regarding the portions of the case schedule leading up to but not including the case dispositive motion stage of the case) and that is consistent with paragraphs 12-21 of Judge Williams' "Rule 16 Scheduling Order -- Patent (ANDA)" (i.e., regarding the portions of the case schedule from the case dispositive motion stage through post-trial motions).; and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties' review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule a Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and both Scheduling Orders can be found on Judge Burke's/Judge Williams' portions of the District Court's website.Ordered by Judge Christopher J. Burke on 10/17/2023. Associated Cases: 1:23-cv-00923-GBW-CJB, 1:23-cv-00879-GBW-CJB, 1:23-cv-00909-GBW-CJB, 1:23-cv-00924-GBW-CJB(dlb) (Entered: 10/17/2023) (0) |
| Oct 13, 2023 | 14 | ORAL ORDER REFERRING CASE TO Magistrate Judge Christopher J. Burke: IT IS HEREBY ORDERED that the above-captioned case is referred to Magistrate Judge Christopher J. Burke to hear and resolve all pre-trial matters up to and including expert discovery matters (but not including summary judgment motions, Daubert motions, pre-trial motions in limine, or the pre-trial conference), subject to 28 U.S.C. §636(b) and any further Order of the Court. ORDERED by Judge Gregory B. Williams on 10/13/23. Associated Cases: 1:23-cv-00923-GBW, 1:23-cv-00879-GBW, 1:23-cv-00909-GBW, 1:23-cv-00924-GBW(ntl) (Entered: 10/13/2023) (0) |
| Oct 6, 2023 | 13 | ORAL ORDER: IT IS HEREBY ORDERED that, not later than thirty (30) days from the date of this Order, the parties shall meet and confer and file a joint proposed Scheduling Order in this action consistent with the applicable form Scheduling Order of Judge Williams, which is posted at http://www/ded/uscourts.gov (See Chambers, Judge Williams, Forms), along with a cover letter requesting the Court to enter the joint proposed Scheduling Order (if there are no disputes or other issues concerning scheduling that the Court needs to address) or to schedule the Scheduling Conference. If there are disputes or other issues the Court needs to address in the joint proposed Scheduling Order, in the cover letter, the parties shall direct the Court to the paragraph numbers in the joint proposed Scheduling Order in which those appear. ORDERED by Judge Gregory B. Williams on 10/6/23. (ntl) (Entered: 10/06/2023) (0) |
| Oct 5, 2023 | 12 | ANSWER to 1 Complaint, by Dexcel Pharma Technologies Limited.(Gaza, Anne) (Entered: 10/05/2023) (28) |
| Sep 7, 2023 | N/A | Pro Hac Vice Attorneys Alexander V. Alfano, Dennies Varughese, Pharm.D., Gaby L. Longsworth, Ph.D. for Dexcel Pharma Technologies Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 09/07/2023) (0) |
| Sep 6, 2023 | N/A | SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., Gaby L. Longsworth, Ph.D., and Alex Alfano filed by Dexcel Pharma Technologies Limited. Signed by Judge Gregory B. Williams on 9/6/23. (ntl) (Entered: 09/06/2023) (0) |
| Sep 5, 2023 | N/A | SO ORDERED, re 9 STIPULATION TO EXTEND TIME to move against, answer, or otherwise respond to Plaintiffs' Complaint to October 5, 2023 filed by Dexcel Pharma Technologies Limited. Signed by Judge Gregory B. Williams on 9/5/23. (ntl) (Entered: 09/05/2023) (0) |
| Sep 5, 2023 | 10 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dexcel PT Israel Limited for Dexcel Pharma Technologies Limited filed by Dexcel Pharma Technologies Limited. (Gaza, Anne) (Entered: 09/05/2023) (2) |
| Sep 5, 2023 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., Gaby L. Longsworth, Ph.D., and Alex Alfano - filed by Dexcel Pharma Technologies Limited. (Gaza, Anne) (Entered: 09/05/2023) (6) |
| Sep 1, 2023 | 9 | STIPULATION TO EXTEND TIME to move against, answer, or otherwise respond to Plaintiffs' Complaint to October 5, 2023 - filed by Dexcel Pharma Technologies Limited. (Gaza, Anne) (Entered: 09/01/2023) (2) |
| Aug 17, 2023 | N/A | SO ORDERED, re 8 MOTION for Pro Hac Vice Appearance of Attorney Thomas H.L. Selby, Stanley E. Fisher, and Seth R. Bowers filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Signed by Judge Gregory B. Williams on 8/17/23. (ntl) (Entered: 08/17/2023) (0) |
| Aug 16, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 08/16/2023) (0) |
| Aug 16, 2023 | 8 | MOTION for Pro Hac Vice Appearance of Attorney Thomas H.L. Selby, Stanley E. Fisher, and Seth R. Bowers - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) (Entered: 08/16/2023) (5) |
| Aug 14, 2023 | 7 | SUMMONS Returned Executed by Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Wyeth LLC, The Scripps Research Institute.Dexcel Pharma Technologies Limited served on 8/14/2023, answer due 9/5/2023. (Dellinger, Megan) (Entered: 08/14/2023) (2) |
| Aug 10, 2023 | 1 | Complaint* (1) |
| Aug 10, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 08/10/2023) (3) |
| Aug 10, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about June 27, 2023. Date of Expiration of Patent: U.S. Patent No. 7,214,695 expires on April 27, 2024. U.S. Patent No. 7,214,696 expires on December 19, 2023. U.S. Patent No. 9,770,441 expires on August 31, 2035.Thirty Month Stay Deadline: November 3, 2026. (mkr) (Entered: 08/10/2023) (1) |
| Aug 10, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,214,695 B2; 7,214,696 B2; 9,770,441 B2. (mkr) (Entered: 08/10/2023) (1) |
| Aug 10, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for FoldRx Pharmaceuticals, LLC, PF PRISM IMB. B.V., Pfizer Inc., The Scripps Research Institute, and Wyeth LLC filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB. B.V., Pfizer Inc., and The Scripps Research Institute, Wyeth LLC. (mkr) (Entered: 08/10/2023) (1) |
| Aug 10, 2023 | 6 | Summons Issued as to Dexcel Pharma Technologies Limited. (mkr) (Entered: 08/10/2023) (2) |
